Healthequity Inc
NASDAQ:HQY

Watchlist Manager
Healthequity Inc Logo
Healthequity Inc
NASDAQ:HQY
Watchlist
Price: 104.5 USD -0.14% Market Closed
Market Cap: 9.1B USD
Have any thoughts about
Healthequity Inc?
Write Note

Intrinsic Value

The intrinsic value of one HQY stock under the Base Case scenario is 79.45 USD. Compared to the current market price of 104.5 USD, Healthequity Inc is Overvalued by 24%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HQY Intrinsic Value
79.45 USD
Overvaluation 24%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Healthequity Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for HQY cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about HQY?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Healthequity Inc

Provide an overview of the primary business activities
of Healthequity Inc.

What unique competitive advantages
does Healthequity Inc hold over its rivals?

What risks and challenges
does Healthequity Inc face in the near future?

Has there been any significant insider trading activity
in Healthequity Inc recently?

Summarize the latest earnings call
of Healthequity Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Healthequity Inc.

Provide P/S
for Healthequity Inc.

Provide P/E
for Healthequity Inc.

Provide P/OCF
for Healthequity Inc.

Provide P/FCFE
for Healthequity Inc.

Provide P/B
for Healthequity Inc.

Provide EV/S
for Healthequity Inc.

Provide EV/GP
for Healthequity Inc.

Provide EV/EBITDA
for Healthequity Inc.

Provide EV/EBIT
for Healthequity Inc.

Provide EV/OCF
for Healthequity Inc.

Provide EV/FCFF
for Healthequity Inc.

Provide EV/IC
for Healthequity Inc.

Show me price targets
for Healthequity Inc made by professional analysts.

What are the Revenue projections
for Healthequity Inc?

How accurate were the past Revenue estimates
for Healthequity Inc?

What are the Net Income projections
for Healthequity Inc?

How accurate were the past Net Income estimates
for Healthequity Inc?

What are the EPS projections
for Healthequity Inc?

How accurate were the past EPS estimates
for Healthequity Inc?

What are the EBIT projections
for Healthequity Inc?

How accurate were the past EBIT estimates
for Healthequity Inc?

Compare the revenue forecasts
for Healthequity Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Healthequity Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Healthequity Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Healthequity Inc compared to its peers.

Compare the P/E ratios
of Healthequity Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Healthequity Inc with its peers.

Analyze the financial leverage
of Healthequity Inc compared to its main competitors.

Show all profitability ratios
for Healthequity Inc.

Provide ROE
for Healthequity Inc.

Provide ROA
for Healthequity Inc.

Provide ROIC
for Healthequity Inc.

Provide ROCE
for Healthequity Inc.

Provide Gross Margin
for Healthequity Inc.

Provide Operating Margin
for Healthequity Inc.

Provide Net Margin
for Healthequity Inc.

Provide FCF Margin
for Healthequity Inc.

Show all solvency ratios
for Healthequity Inc.

Provide D/E Ratio
for Healthequity Inc.

Provide D/A Ratio
for Healthequity Inc.

Provide Interest Coverage Ratio
for Healthequity Inc.

Provide Altman Z-Score Ratio
for Healthequity Inc.

Provide Quick Ratio
for Healthequity Inc.

Provide Current Ratio
for Healthequity Inc.

Provide Cash Ratio
for Healthequity Inc.

What is the historical Revenue growth
over the last 5 years for Healthequity Inc?

What is the historical Net Income growth
over the last 5 years for Healthequity Inc?

What is the current Free Cash Flow
of Healthequity Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Healthequity Inc.

Business Breakdown

Healthequity Inc. is a prominent player in the health benefits space, focusing on health savings and spending accounts that empower individuals and families to manage their healthcare expenses more effectively. The company stands at the intersection of healthcare and technology, providing innovative solutions that facilitate tax-advantaged savings for medical expenses through Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs). Founded in 2002, Healthequity has experienced robust growth driven by a growing awareness of the importance of consumer-directed healthcare and increasing employer sponsorship of HSAs as a means to attract and retain talent. By offering seamless digit...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Healthequity Inc

Current Assets 495.6m
Cash & Short-Term Investments 326.9m
Receivables 108.5m
Other Current Assets 60.3m
Non-Current Assets 3B
PP&E 51.1m
Intangibles 2.9B
Other Non-Current Assets 65.4m
Current Liabilities 120.9m
Accounts Payable 10.6m
Accrued Liabilities 110.3m
Non-Current Liabilities 1.2B
Long-Term Debt 1.1B
Other Non-Current Liabilities 135.1m
Efficiency

Earnings Waterfall
Healthequity Inc

Revenue
1.1B USD
Cost of Revenue
-384.1m USD
Gross Profit
715.1m USD
Operating Expenses
-535.9m USD
Operating Income
179.2m USD
Other Expenses
-73.5m USD
Net Income
105.7m USD

Free Cash Flow Analysis
Healthequity Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q2, HealthEquity achieved a 23% year-over-year revenue growth, ending with over 16 million total accounts and 9 million HSAs, reflecting $29 billion in HSA assets. Adjusted EBITDA rose by 46% to $128.3 million. The company completed the BenefitWallet acquisition, adding 216,000 HSAs and $1 billion in assets. The fiscal 2025 revenue guidance was increased to $1.165 billion-$1.185 billion, with non-GAAP net income projected between $265 million and $280 million. A share repurchase authorization of $300 million was also announced, aiming to enhance shareholder value and reduce debt .

What is Earnings Call?
Fundamental Scores

HQY Profitability Score
Profitability Due Diligence

Healthequity Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Negative Free Cash Flow
51/100
Profitability
Score

Healthequity Inc's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

HQY Solvency Score
Solvency Due Diligence

Healthequity Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
High Altman Z-Score
Long-Term Solvency
Low D/E
56/100
Solvency
Score

Healthequity Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HQY Price Targets Summary
Healthequity Inc

Wall Street analysts forecast HQY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HQY is 108.98 USD with a low forecast of 95.95 USD and a high forecast of 136.5 USD.

Lowest
Price Target
95.95 USD
8% Downside
Average
Price Target
108.98 USD
4% Upside
Highest
Price Target
136.5 USD
31% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for HQY?

Click here to dive deeper.

Dividends

Healthequity Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for HQY is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

HQY Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

HQY News

Other Videos

Profile

Healthequity Inc Logo
Healthequity Inc

Country

United States of America

Industry

Health Care

Market Cap

9.1B USD

Dividend Yield

0%

Description

HealthEquity, Inc. provides range of solutions for managing health care accounts. The company is headquartered in Draper, Utah and currently employs 3,688 full-time employees. The company went IPO on 2014-07-31. The company offer multiple cloud-based platforms, accessed by its members online via a desktop or mobile device, through which individuals can make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings and make investment choices. Consumers and employers use its platforms to manage tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), Consolidated Omnibus Budget Reconciliation Act (COBRA) administration, and others. The company also offers a mutual fund investment platform and access to an online-only automated investment advisory service to all its members.

Contact

UTAH
Draper
15 W Scenic Pointe Dr Ste 100
+18017271000.0
healthequity.com

IPO

2014-07-31

Employees

3 688

Officers

President, CEO & Director
Mr. Jon Kessler
Founder & Vice Chairman
Dr. Stephen D. Neeleman
CFO & Executive VP
Mr. James M. Lucania
Executive VP & CTO
Mr. Elimelech Rosner
Executive VP, General Counsel & Secretary
Mr. Delano Ladd
Vice President of Investor Relations
Mr. Richard Putnam
Show More
Executive Vice President of Sales & Relationship Management
Mr. Steve Lindsay
Executive Vice President of Corporate Development & Strategy
Mr. Brad Bennion
Executive VP & Chief Marketing Officer
Ms. Tia Padia
Executive VP & Chief People Officer
Cheryl King
Show Less

See Also

Discover More
What is the Intrinsic Value of one HQY stock?

The intrinsic value of one HQY stock under the Base Case scenario is 79.45 USD.

Is HQY stock undervalued or overvalued?

Compared to the current market price of 104.5 USD, Healthequity Inc is Overvalued by 24%.

Back to Top